Medpace Inc. (MEDP)
319.56
-7.76 (-2.37%)
At close: Mar 03, 2025, 3:59 PM
319.17
-0.12%
After-hours: Mar 03, 2025, 04:00 PM EST
Medpace Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Revenue | 2.11B | 1.89B | 1.46B | 1.14B | 925.92M | 860.97M | 704.59M | 436.15M | 421.58M | 359.06M | 290.04M | 272.89M |
| Cost of Revenue | 1.45B | 1.36B | 1.03B | 814.22M | 647.2M | 615.27M | 489.06M | 261.46M | 249.47M | 202.66M | 156.31M | 148.4M |
| Gross Profit | 656.3M | 524.5M | 432.44M | 328.15M | 278.73M | 245.7M | 215.53M | 174.69M | 172.11M | 156.39M | 133.73M | 124.49M |
| Operating Income | 446.87M | 336.82M | 278.7M | 198.62M | 167.04M | 127.26M | 101.05M | 64.86M | 52.49M | 33.08M | 26M | 58.86M |
| Interest Income | n/a | n/a | 2.9M | 105K | 307K | 1.57M | n/a | n/a | n/a | n/a | 26.46M | n/a |
| Pretax Income | 475.92M | 335.68M | 282.86M | 201.85M | 168.53M | 124.83M | 93.95M | 56.95M | 21.96M | -7.83M | -21.26M | 39.15M |
| Net Income | 404.39M | 282.81M | 245.21M | 181.39M | 144.93M | 100.16M | 72.89M | 39.03M | 13.39M | -8.67M | -15.57M | 24.84M |
| Selling & General & Admin | 180.18M | 161.35M | 131.4M | 108.42M | 92.16M | 95.25M | 75.68M | 63.36M | 61.51M | 57M | 39.67M | 35.11M |
| Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Expenses | 29.25M | 26.33M | 22.34M | 21.12M | 19.53M | 23.19M | 1.06M | -354K | -423K | 174K | n/a | 2.39M |
| Operating Expenses | 209.44M | 187.68M | 153.74M | 129.54M | 111.68M | 118.43M | 114.48M | 109.83M | 119.62M | 126.52M | 128.54M | 65.63M |
| Interest Expense | n/a | 488K | 2.9M | 105K | 307K | 1.57M | 8.16M | 7.56M | 19.38M | 27.26M | n/a | 18M |
| Selling & Marketing Expenses | n/a | 1.5M | 1.3M | 1.2M | 700K | 700K | 800K | 600K | 600K | 400K | 300K | 300K |
| Cost & Expenses | 1.66B | 1.55B | 1.18B | 943.76M | 758.88M | 733.71M | 603.54M | 371.29M | 369.09M | 329.18M | 284.85M | 214.03M |
| Income Tax | 71.54M | 52.87M | 37.49M | 20M | 23.15M | 24.39M | 20.77M | 17.82M | 8.53M | 843K | 5.69M | 14.3M |
| Shares Outstanding (Basic) | 30.96M | 30.72M | 32.39M | 35.86M | 35.63M | 35.88M | 35.55M | 39.06M | 35.69M | 39.63M | 29.43M | 38.35M |
| Shares Outstanding (Diluted) | 32.01M | 31.84M | 33.67M | 37.7M | 37.71M | 37.58M | 36.91M | 39.84M | 36.33M | 39.63M | 29.43M | 38.35M |
| EPS (Basic) | 13.06 | 9.20 | 7.57 | 5.06 | 4.07 | 2.79 | 2.05 | 1.00 | 0.38 | -0.28 | -0.53 | 1.33 |
| EPS (Diluted) | 12.63 | 8.88 | 7.28 | 4.81 | 3.84 | 2.67 | 1.97 | 0.98 | 0.37 | -0.28 | -0.53 | 1.28 |
| EBITDA | 446.87M | 363.15M | 301.04M | 219.73M | 186.57M | 150.45M | 140.91M | 110.98M | 110.6M | 102.6M | 94.06M | 89.38M |
| Depreciation & Amortization | n/a | 26.33M | 40.36M | 37.41M | 33.45M | 23.19M | 38.8M | 46.47M | 58.11M | 69.52M | 68.06M | 30.52M |